Information of potential product deviation of NovoSeven® 2mg in the market

A Dear Healthcare Professional Letter has been issued by Novo Nordisk Pharma to inform healthcare professionals of an issue on a specific production line that is manufacturing NovoSeven® 2 mg and resulted in the under-filling of some of NovoSeven® 2mg. The likelihood of a patient receiving an under-filled vial is very low. This is due to extensive manual inspections during production, as a result of which, most under-filled vials were identified and removed before release. Based on the NovoSeven® label, clinical patient monitoring is necessary. When required, repeated dosing is recommended to achieve haemostasis as per the NovoSeven® label. Healthcare professionals are advised to refer to the letter for dosing details. Please refer to the letter for details.

Healthcare professional, Industry member, Therapeutic Products
Published:

Dear Healthcare Professional Letters

22 Jul 2024

Only abstracts of the Dear Healthcare Professional Letters (DHCPL) are provided on this website. Details of the letters can be found on the MOH Alert System, which is accessible via the Health Professionals Portal (HPP). HPP is a one-stop portal for all healthcare professionals in Singapore. Dentists, medical doctors and pharmacists may access HPP at https://www.hpp.moh.gov.sg/, and follow the procedures below to access the MOH Alert system.

Step 1: Scroll down to the bottom navigation panel of the HPP web page. Under the Healthcare Professionals section, expand the dropdown option for ‘Healthcare Professional Portal’ and select your profession. You will be redirected to the specific HPP web page to log in.

Step 2: Click on the Restricted Content icon on the left panel of the web page and log in via SingPass.

Step 3: Click on the MOH Alert icon under the ‘Applications’ section.

Step 4: Click on the Drug Alert tab to view the DHCPLs.